{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "08033 Thromboprophylaxis in labour delivery and caesarean  6.1.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "THROMBOPROPHYLAXIS AND TREATMENT DURING LABOUR AND DELIVERY INCLUDING CAESAREAN SECTION"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "08033"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "6.1"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP)"
                    },
                    {
                        "text": "Guideline"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "Midwives, Obstetricians, Paediatricians"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "22 August 2019"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "21 August 2022"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "Intrapartum NICE Guidelines RCOG Guideline 2015"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "9,12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Women's and Children's"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Anita Dutta, Consultant for Obstetrics and Gynaecology"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2610 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2612 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "n/a"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "n/a"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Miss Rao, Lead Consultant for Obstetrics and Gynaecology"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "21June 2019"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Document Ratification Group"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "26 June 2019"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Document Ratification Group"
                    },
                    {
                        "text": "Date: August 2019"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "Intranet & Website. Notified on Staff Focus"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "08033 Thromboprophylaxis in labour delivery and caesarean  6.1.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 13,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With:"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Anita Rao/ Alison Cuthbertson"
                    },
                    {
                        "text": "Clinical Director for Women's, Children's Directorate"
                    },
                    {
                        "text": "21 June 2019"
                    },
                    {
                        "text": "Alison Cuthbertson"
                    },
                    {
                        "text": "Head of Midwifery / Nursing"
                    },
                    {
                        "text": "Madhu Joshi"
                    },
                    {
                        "text": "Consultant for Obstetrics and Gynaecology"
                    },
                    {
                        "text": "Angela Woolfenden"
                    },
                    {
                        "text": "Lead Midwife Community"
                    },
                    {
                        "text": "Amanda Dixon"
                    },
                    {
                        "text": "Lead Midwife Acute Inpatient Services"
                    },
                    {
                        "text": "Chris Berner"
                    },
                    {
                        "text": "Lead Midwife Clinical Governance"
                    },
                    {
                        "text": "Claire Fitzgerald"
                    },
                    {
                        "text": "Pharmacist"
                    },
                    {
                        "text": "Ruth Byford"
                    },
                    {
                        "text": "Warner Library"
                    },
                    {
                        "text": "28 June 2019"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 1,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "04071 Policy for standard infection prevention precautions 07072 Management of a patient reporting an antepartum haemorrhage 07040 Management of pregnant and postnatal patients refusing blood products 04184 Manual of blood transfusion policies and procedures 06029 Transfer of mothers and babies to different care settings 07024 Emergency transport of blood specimens in the event of major obstetric haemorrhage 08014 VTE risk assessment and thromboprophylaxis in Maternity 12007 Management of women with venous thromboembolism (VTE), deep vein thrombosis (DVT) or pulmonary embolism (PE) during antenatal and postnatal period"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 10,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Nina Smethurst"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "July 2003"
                    },
                    {
                        "text": "2.0"
                    },
                    {
                        "text": "Julie Bishop"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "July 2006"
                    },
                    {
                        "text": "3.0"
                    },
                    {
                        "text": "Sajida Ajjawi"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "March 2008"
                    },
                    {
                        "text": "3.1"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Equality and diversity; audit and monitoring"
                    },
                    {
                        "text": "November 2009"
                    },
                    {
                        "text": "4.0"
                    },
                    {
                        "text": "T T Wai"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "January 2016"
                    },
                    {
                        "text": "5.0"
                    },
                    {
                        "text": "Dr Richard Haines"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "07 June 2016"
                    },
                    {
                        "text": "6.0"
                    },
                    {
                        "text": "Anita Dutta"
                    },
                    {
                        "text": "Full review"
                    },
                    {
                        "text": "22 August 2019"
                    },
                    {
                        "text": "6.1"
                    },
                    {
                        "text": "Rachel Smith"
                    },
                    {
                        "text": "Clarity for High risk age limit (change of wording in VTE Assessment in Maternity notes) Response to an Action Plan from a SI"
                    },
                    {
                        "text": "02 March 2021"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 7,
            "data": {
                "is_heading": 1,
                "text": "INDEX"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 8,
            "data": {
                "is_heading": 0,
                "text": "Appendix A - Antenatal and Postnatal Prophylactic Dose of LMWH Appendix B - Therapeutic Dose of LMWH"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 9,
            "data": {
                "is_heading": 0,
                "text": "Appendix C - Obstetric Thromboprophylaxis Risk Assessment and"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 10,
            "data": {
                "is_heading": 0,
                "text": "Management"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 11,
            "data": {
                "is_heading": 0,
                "text": "Appendix D \u2013 Preliminary Equality Analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 12,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Purpose"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 13,
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "This guideline is designed to help maternity staff to manage patients who are on thromboprophylaxis or treatment dose of heparin, and they are in labour and delivery including caesarean section."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 14,
            "data": {
                "is_heading": 0,
                "text": "(Refer to the guideline entitled \u2018VTE Risk Assessment and Thromboprophylaxis in Maternity';register number 08014 and \u201812007)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 15,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Equality Impact Assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 16,
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "Mid Essex Hospital Services NHS Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 17,
            "data": {
                "is_heading": 0,
                "text": "(Refer to Appendix D)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 18,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Background"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 19,
            "data": {
                "is_heading": 0,
                "prefix": 3.1,
                "text": "Pregnancy is a risk factor for venous thromboembolism (VTE) and is associated with a ten-fold increase compared with the risk for non-pregnant patients."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 20,
            "data": {
                "is_heading": 0,
                "prefix": 3.2,
                "text": "Pulmonary thromboembolism (PTE) is the most common direct cause of maternal death in the UK. Three successive reports from the Confidential Enquiries into Maternal Deaths have highlighted failures in recognising risk factors for VTE and employing adequate prophylaxis."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 21,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Risk Assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 22,
            "data": {
                "is_heading": 0,
                "text": "(Refer to the guideline entitled \u2018VTE Risk Assessment and Thromboprophylaxis in Maternity'; register number 08014; point 5.0)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 23,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Recommendations"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 24,
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Women who are on pharmacological antenatal thromboprophylaxis require anaesthetic referral to discuss an individual plan for intrapartum and delivery analgesic options."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 25,
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "Very high risk patients require multidisciplinary team management i.e. haematologist, obstetrician and anaesthetist involvement."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 26,
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "All women who require elective caesarean section should have a VTE assessment at 36 weeks or at gestation appropriate for clinical condition in the Antenatal Clinic."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 27,
            "data": {
                "is_heading": 0,
                "prefix": 5.4,
                "text": "All women who require emergency caesarean section require VTE assessment when decision for caesarean section has been made."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 28,
            "data": {
                "is_heading": 0,
                "prefix": 5.5,
                "text": "Full blood count (FBC), clotting and group and save \u2013 to be performed at least 3 days prior to the day of elective caesarean section or induction of labour and on the day if the patient goes into labour."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 29,
            "data": {
                "is_heading": 0,
                "prefix": 9.0,
                "text": "Anaesthetist may consider regional analgesia provided INR less than 1.5, platelets count >80 x  /L; but every case should be considered on its merits."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 30,
            "data": {
                "is_heading": 0,
                "prefix": 5.7,
                "text": "Elective induction of labour may be indicated in some women (particularly those on high-dose prophylactic or treatment doses of LMWH) to help plan for thromboprophylaxis around delivery."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 31,
            "data": {
                "is_heading": 0,
                "prefix": 5.8,
                "text": "Gestation as an indication for induction of labour should be based on other obstetric indications and favourability of cervix; as stopping of LMWH during a long induction process will expose women to high risk of VTE."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 32,
            "data": {
                "is_heading": 0,
                "prefix": 5.9,
                "text": "If LMWH precludes regional techniques (for example, the woman who presents in spontaneous labour within 12 hours of taking a LMWH dose) alternative analgesia such as opiate-based intravenous patient controlled analgesia can be offered."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 33,
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Advise anaesthetic registrar of the patient's admission to the Maternity Unit who were on antenatal LMWH."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 34,
            "data": {
                "is_heading": 0,
                "prefix": 10.0,
                "text": "All women who have had a caesarean section in labour require postpartum clexane (thromboprophylaxis) for at least 10 days. If elective caesarean section, they should receive  days of LMWH postnatally only if other risk factors are present."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 35,
            "data": {
                "is_heading": 0,
                "prefix": 5.12,
                "text": "Women may require clexane for a longer duration dependant on individual risk  assessment."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 36,
            "data": {
                "is_heading": 0,
                "text": "(Refer to VTE risk assessment for maternity cases)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 37,
            "data": {
                "is_heading": 0,
                "prefix": 5.13,
                "text": "The anaesthetic registrar should prescribe the initial dose (time to be given) and duration of postnatal clexane as per clinical requirement."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 38,
            "data": {
                "is_heading": 0,
                "prefix": 5.14,
                "text": "Postpartum thromboprophylaxis should be given as soon as possible after delivery, provided that there is no postpartum haemorrhage."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 39,
            "data": {
                "is_heading": 0,
                "prefix": 5.15,
                "text": "Those with postpartum haemorrhage should be fitted with thromboembolic deterrent stockings."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 40,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Spontaneous Labour and who are on Antenatal LMWH"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 41,
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "To advise women not to inject further LMWH, if they have any vaginal bleeding or once regular contraction begins."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 42,
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "They should be reassessed on admission to hospital and further doses should be prescribed by medical staff."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 43,
            "data": {
                "is_heading": 0,
                "prefix": 6.3,
                "text": "Inform anaesthetist on admission of patient to Maternity Unit."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 44,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "For Induction of Labour in Women Receiving Antenatal LMWH"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 45,
            "data": {
                "is_heading": 1,
                "prefix": 7.1,
                "text": "For women receiving prophylactic dose of LMWH, omit the injection on the day of induction of labour."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 46,
            "data": {
                "is_heading": 1,
                "prefix": 7.2,
                "text": "For women receiving high prophylactic or therapeutic doses of LMWH, the dose of heparin should be reduced to its thromboprophylactic dose on the day before induction of labour and, if appropriate, continued in this dose during labour."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 47,
            "data": {
                "is_heading": 0,
                "prefix": 5000.0,
                "text": "If LMWH has not been given for  hours and the woman (who was on high prophylactic/ therapeutic dose) has not yet delivered; and there is concern about delaying further doses of LMWH, a prophylactic dose ofiu subcutaneously of unfractionated heparin should be administered."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 48,
            "data": {
                "is_heading": 0,
                "prefix": 7.4,
                "text": "Repeat unfractionated heparin every 12 hours until LMWH can be resumed after delivery."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 49,
            "data": {
                "is_heading": 0,
                "prefix": 7.5,
                "text": "The required interval between a prophylactic dose of unfractionated heparin and regional analgesia or anaesthesia is lesser than with LMWH (12 hours) and there is less concern regarding neuraxial haematomas with unfractionated heparin."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 50,
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "For Elective Caesarean Section in Women Receiving Antenatal LMWH"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 51,
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "The woman should receive a thromboprophylactic dose of LMWH on the day before delivery. On the day of delivery, any morning dose should be omitted and the operation should be performed that morning."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 52,
            "data": {
                "is_heading": 0,
                "prefix": 40.0,
                "text": "For women receiving high prophylactic or therapeutic doses of LMWH, the dose of heparin should be reduced to its thromboprophylactic dose (Clexane \u2264  mg) on the day before caesarean section."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 53,
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Regional Analgesia and to Minimise the Risk of Epidural Haematoma"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 54,
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "Regional techniques should not be used until at least 12 hours after the previous prophylactic dose of LMWH and at least 24 hours after the last therapeutic dose of LMWH."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 55,
            "data": {
                "is_heading": 0,
                "prefix": 12.0,
                "text": "Subcutaneous unfractionated heparin should be discontinued  hours before induction or regional anaesthesia; and intravenous unfractionated heparin stopped 6 hours before these procedures."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 56,
            "data": {
                "is_heading": 0,
                "prefix": 40.0,
                "text": "Trust anaesthetists consider clexane \u2264  mg as a prophylactic dose and clexane >40 mg as a treatment dose, when considering regional analgesia."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 57,
            "data": {
                "is_heading": 0,
                "prefix": 9.4,
                "text": "LMWH should not be given for 4 hours after use of spinal anaesthesia or after the epidural catheter has been removed; for 6 hours if the procedure was traumatic."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 58,
            "data": {
                "is_heading": 0,
                "prefix": 9.5,
                "text": "The epidural cannula should not be removed within 12 hours of the most recent LMWH injection."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 59,
            "data": {
                "is_heading": 0,
                "prefix": 9.6,
                "text": "Epidural anaesthesia can be sited only after discussion with a senior anaesthetist."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 60,
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Specific Surgical Measures for Anticoagulated Women Undergoing Delivery by Caesarean Section"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 61,
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "Bleeding complications appear to be very uncommon with LMWH. But, there is an increased risk of wound haematoma following caesarean section with both unfractionated heparin and LMWH of around 2%."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 62,
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "In women receiving therapeutic doses of LMWH, wound drains (abdominal and rectus sheath) should be considered at caesarean section and the skin incision should be closed with staples or interrupted sutures to allow drainage of any haematoma."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 63,
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Management for Women at High Risk of Haemorrhage"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 64,
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "Any woman who is considered to be at high-risk of haemorrhage and in whom continued heparin treatment is considered essential should be managed with intravenous, unfractionated heparin until the risk factors for haemorrhage have resolved."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 65,
            "data": {
                "is_heading": 0,
                "prefix": 11.2,
                "text": "Risk factors include major antepartum haemorrhage, coagulopathy, progressive wound haematoma, suspected intra-abdominal bleeding and postpartum haemorrhage."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 66,
            "data": {
                "is_heading": 0,
                "prefix": 11.3,
                "text": "Unfractionated heparin has a shorter half-life than LMWH and its activity is more completely reversed with protamine sulphate."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 67,
            "data": {
                "is_heading": 0,
                "prefix": 11.4,
                "text": "If a woman develops a haemorrhagic problem while on LMWH, the treatment should be stopped and expert haematological advice sought."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 68,
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Postpartum Management"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 69,
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "For thromboprophylaxis refer to the guideline entitled \u2018VTE Risk Assessment and Thromboprophylaxis in Maternity'; register number 08014."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 70,
            "data": {
                "is_heading": 0,
                "prefix": 12007.0,
                "text": "For treatment of DVT or PE refer to the guideline entitled \u2018Management of women with venous thromboembolism (VTE), deep vein thrombosis (DVT) or pulmonary embolism (PE) during antenatal and postnatal period'; register number"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 71,
            "data": {
                "is_heading": 0,
                "prefix": 12.3,
                "text": "The anaesthetic registrar should prescribe postnatal clexane subcutaneous as per clinical requirement i.e. time of initial dose to be given and total duration."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 72,
            "data": {
                "is_heading": 0,
                "prefix": 12.4,
                "text": "The first thromboprophylactic dose of LMWH should be given as soon as possible 4-8 hours after delivery provided that there is no postpartum haemorrhage and who has no regional analgesia"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 73,
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "If there has been regional analgesia, LMWH should be given byhours after delivery or 4 hours after removal of the epidural catheter; for 6 hours if the procedure was traumatic."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 74,
            "data": {
                "is_heading": 0,
                "prefix": 12.0,
                "text": "If the epidural catheter is left in place after delivery for the purpose of postpartum analgesia, it should be removed  hours after last dose of LMWH and 4 hours before the next dose of LMWH."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 75,
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Staff and Training"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 76,
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "All qualified midwifery and obstetric staff are fully trained to perform an initial assessment antenatally and to inform the appropriate multidisciplinary members as necessary."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 77,
            "data": {
                "is_heading": 0,
                "prefix": 13.2,
                "text": "Qualified staff should assist midwifery and medical trainee's to learn how to assess and identify patients who may require thrombophrophylaxis as part of their education and skills where appropriate to ensure safe competent practitioner."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 78,
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Professional Midwifery Advocate"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 79,
            "data": {
                "is_heading": 0,
                "prefix": 14.1,
                "text": "Professional Midwifery Advocates provide a mechanism of support and guidance to women and midwives. Professional Midwifery Advocates are experienced practising midwives who have undertaken further education in order to supervise midwifery services and to advise and support midwives and women in their care choices."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 80,
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Infection Prevention"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 81,
            "data": {
                "is_heading": 0,
                "prefix": 15.1,
                "text": "All staff should follow Trust guidelines on infection prevention by ensuring that they effectively \u2018decontaminate their hands' before and after each procedure."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 82,
            "data": {
                "is_heading": 0,
                "prefix": 15.2,
                "text": "All staff should ensure that they follow Trust guidelines on infection prevention. All invasive devices must be inserted and cared for using High Impact Intervention guidelines to reduce the risk of infection and deliver safe care. This care should be recorded in the Saving Lives High Impact Intervention Monitoring Tool Paperwork (Medical Devices)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 83,
            "data": {
                "is_heading": 1,
                "prefix": 16.0,
                "text": "Audit and Monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 84,
            "data": {
                "is_heading": 0,
                "prefix": 16.1,
                "text": "Topics for formal audit are selected on an annual basis in accordance with the requirements the Clinical Audit Strategy and Policy (register number 08076), the Corporate Clinical Audit and Quality Improvement Project Plan and the Maternity Annual Audit Work Plan."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 85,
            "data": {
                "is_heading": 0,
                "prefix": 16.2,
                "text": "Audit of compliance with this guideline will be considered based on national and local audit findings and clinical governance data identifying themes suggesting care delivery is suboptimal. If audit of this guideline is identified as a priority, the Women's and Children's Clinical Audit Group will identify a lead for the audit."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 86,
            "data": {
                "is_heading": 0,
                "prefix": 16.3,
                "text": "The findings of the audit will be reported to and approved by the Women's and Children's Clinical Audit Group and an action plan with named leads and timescales will be developed to address any identified deficiencies. Performance against the action plan will be monitored by this group at subsequent meetings."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 87,
            "data": {
                "is_heading": 0,
                "prefix": 16.4,
                "text": "Any significant concerns relating to compliance with the requirements of this guideline will be entered on the local Risk Assurance Framework."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 88,
            "data": {
                "is_heading": 0,
                "prefix": 16.5,
                "text": "Key findings and learning points from the audit will be submitted to the Clinical Governance Group within the quarterly Women's and Children's Directorate Governance report."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 89,
            "data": {
                "is_heading": 0,
                "prefix": 16.6,
                "text": "Key findings and learning points will be disseminated to relevant staff."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 90,
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "Guideline Management"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 91,
            "data": {
                "is_heading": 0,
                "prefix": 17.1,
                "text": "As an integral part of the knowledge, skills framework, staff are appraised annually to ensure competency in computer skills and the ability to access the current approved guidelines via the Trust's intranet site."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 92,
            "data": {
                "is_heading": 0,
                "prefix": 17.2,
                "text": "Quarterly memos are sent to line managers to disseminate to their staff the most currently approved guidelines available via the intranet and clinical guideline folders, located in each designated clinical area."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 93,
            "data": {
                "is_heading": 1,
                "prefix": 18.0,
                "text": "Communication"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 94,
            "data": {
                "is_heading": 0,
                "prefix": 18.1,
                "text": "A quarterly \u2018maternity newsletter' is issued and available to all staff including an update on the latest \u2018guidelines' information such as a list of newly approved guidelines for staff to acknowledge and familiarise themselves with and practice accordingly."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 95,
            "data": {
                "is_heading": 0,
                "prefix": 18.2,
                "text": "Approved guidelines are published monthly in the Trust's Focus Magazine that is sent via email to all staff."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 96,
            "data": {
                "is_heading": 1,
                "prefix": 19.0,
                "text": "References"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 97,
            "data": {
                "is_heading": 0,
                "text": "National Institute for Health and Care of Clinical Excellence (2012) Venous thromboembolic diseases: the diagnosis, management of venous thromboembolic diseases and the role of thrombophilia testing (updated 2015) NICE clinical guideline CG144, June."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 98,
            "data": {
                "is_heading": 0,
                "text": "Available at: https://www.nice.org.uk/guidance/cg144"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 99,
            "data": {
                "is_heading": 0,
                "text": "Royal College of Obstetricians and Gynaecologists (2015); Thromboembolic disease in Thrombosis and embolism during pregnancy and the puerperium: acute management; Green-top Guideline No. 37b"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 100,
            "data": {
                "is_heading": 0,
                "text": "Available at: https://www.rcog.org.uk/en/guidelines-research- services/guidelines/gtg37b/; April 2015"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 101,
            "data": {
                "is_heading": 0,
                "text": "Prevention and Treatment of Venous Thrombo-Embolism (VTE): Risk Assessment and Prophylaxis; MEHT Clinical Guideline; Register No: 09051"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 102,
            "data": {
                "is_heading": 0,
                "text": "National Institute for Health and Care Excellence (2018) Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism NG89"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 103,
            "data": {
                "is_heading": 0,
                "text": "Available at: https://www.nice.org.uk/guidance/ng89"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 104,
            "data": {
                "is_heading": 0,
                "text": "Saving Mothers' Lives; Reviewing maternal deaths to make"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 105,
            "data": {
                "is_heading": 0,
                "text": "motherhood safer: 2006\u20132008; BJOG An International Journal of Obstetrics and Gynaecology; Centre for Maternal and Child Enquiries; Volume 118, Supplement 1, March 2011"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 106,
            "data": {
                "is_heading": 0,
                "text": "Available at: https://doi.org/10.1111/j.1471-0528.2010.02847"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 107,
            "data": {
                "is_heading": 0,
                "prefix": 3.0,
                "text": "Monteiro, R, Salman, M et al, 2019 Analgesia, anaesthesia and pregnancy; a practical guide.4th ed. Cambridge University Press rd edition available to loan from"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 108,
            "data": {
                "is_heading": 0,
                "text": "Warner Library"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 109,
            "data": {
                "is_heading": 1,
                "text": "Appendix A"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 110,
            "data": {
                "is_heading": 1,
                "text": "Antenatal and postnatal prophylactic dose of LMWH"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 111,
            "data": {
                "is_heading": 0,
                "text": "Thromboprophylaxis and Treatment During Labour and Delivery Including Caesarean Section/ 08033 / 6.1"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 112,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 113,
            "data": {
                "is_heading": 1,
                "text": "Weight"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 114,
            "data": {
                "is_heading": 0,
                "prefix": 50.0,
                "text": "kg 50\u201390 kg 91\u2013130 kg 131\u2013170 kg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 115,
            "data": {
                "is_heading": 0,
                "text": "> 170 kg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 116,
            "data": {
                "is_heading": 1,
                "text": "Enoxaparin  20 mg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 117,
            "data": {
                "is_heading": 0,
                "text": "40 mg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 118,
            "data": {
                "is_heading": 0,
                "text": "60 mg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 119,
            "data": {
                "is_heading": 0,
                "text": "80 mg 0.6 mg/kg/day"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 120,
            "data": {
                "is_heading": 1,
                "text": "Dalteparin 2500 units 5000 units 7500 unit 10000 unit"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 121,
            "data": {
                "is_heading": 0,
                "text": "75 units/kg/day"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 122,
            "data": {
                "is_heading": 1,
                "text": "Tinzaparin"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 123,
            "data": {
                "is_heading": 0,
                "text": "3500 units daily 4500 units daily 7000 unit daily 9000 unit daily 75 units/kg/day"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 124,
            "data": {
                "is_heading": 1,
                "text": "Appendix B"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 125,
            "data": {
                "is_heading": 1,
                "text": "Therapeutic dose of LMWH Calculation of initial doses of drugs by early pregnancy weight"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 126,
            "data": {
                "is_heading": 0,
                "text": "Enoxaparin 1 mg/kg twice daily;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 127,
            "data": {
                "is_heading": 0,
                "text": "Dalteparin 100 units/kg twice daily;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 128,
            "data": {
                "is_heading": 0,
                "text": "Tinzaparin (175 units/kg) once daily."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 129,
            "data": {
                "is_heading": 1,
                "text": "LMWH Therapeutic Dose"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 130,
            "data": {
                "is_heading": 0,
                "text": "Initial dose Early pregnancy weight (kg)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 131,
            "data": {
                "is_heading": 0,
                "prefix": 50.0,
                "text": "50\u201369 70\u201389 > 90"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 132,
            "data": {
                "is_heading": 0,
                "prefix": 8000.0,
                "text": "Enoxaparin 40 mg bd  mg bd  mg bd 100 mg bd Dalteparin iu bd iu bd iu bd 10,000 iu bd"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 133,
            "data": {
                "is_heading": 0,
                "text": "Tinzaparin 175 units/kg once daily (all weights)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 134,
            "data": {
                "is_heading": 0,
                "text": "bd = twice daily"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 135,
            "data": {
                "is_heading": 1,
                "text": "Appendix C"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 136,
            "data": {
                "is_heading": 1,
                "text": "Risk Assessment for VTE Antenatal Notes"
            }
        },
        {
            "type": "image",
            "sequence_num": 137,
            "data": {
                "url": "08033 Thromboprophylaxis in labour delivery and caesarean  6.1.003.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 138,
            "data": {
                "is_heading": 1,
                "text": "Risk Assessment for VTE Labour Care Notes"
            }
        },
        {
            "type": "image",
            "sequence_num": 139,
            "data": {
                "url": "08033 Thromboprophylaxis in labour delivery and caesarean  6.1.003.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 140,
            "data": {
                "is_heading": 1,
                "text": "Risk Assessment for VTE Postnatal Maternal Notes"
            }
        },
        {
            "type": "image",
            "sequence_num": 141,
            "data": {
                "url": "08033 Thromboprophylaxis in labour delivery and caesarean  6.1.004.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 142,
            "data": {
                "is_heading": 0,
                "text": "Thromboprophylaxis and Treatment During Labour and Delivery Including Caesarean Section/ 08033 / 6.1"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 143,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "image",
            "sequence_num": 144,
            "data": {
                "url": "08033 Thromboprophylaxis in labour delivery and caesarean  6.1.005.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 145,
            "data": {
                "is_heading": 1,
                "text": "Appendix D: Preliminary Equality Analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 146,
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: Thromboprophylaxis and Treatment during Labour and Delivery Including Caesarean Section/ 08033"
            }
        },
        {
            "type": "table",
            "sequence_num": 147,
            "data": {
                "num_rows": 9,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "A change in a service to patients"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A change to an existing policy"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "A change to the way staff work"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A new policy"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Full Review"
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "3 year review"
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Patients and clinicians"
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change? b) If so, with whom?"
                    },
                    {
                        "text": "Refer to pages 1 and 2"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 148,
            "data": {
                "is_heading": 1,
                "text": "Preliminary analysis completed by:"
            }
        },
        {
            "type": "table",
            "sequence_num": 149,
            "data": {
                "num_rows": 1,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Anita Dutta"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Consultant Obstetrician"
                    },
                    {
                        "text": "Date"
                    },
                    {
                        "text": "June 2019"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 150,
            "data": {
                "is_heading": 0,
                "text": "Thromboprophylaxis and Treatment During Labour and Delivery Including Caesarean Section/ 08033 / 6.1"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 151,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        }
    ]
}